Clinical trials: Fall Injury

Seasonal Allergic Rhinitis

Montelukast in Seasonal Allergic Rhinitis: Fall 2001 Study (0476-240)

• Completed
• Age: 15 to 85 years
• Phase 3
• Results posted

This is a study to evaluate the treatment effect of montelukast 10 mg taken in the morning, versus placebo, in patients with seasonal allergic rhinitis. Loratadine is included in the study as an active control.

Trial name

NCT00963469

Testing

montelukast sodium, Comparator: loratadine

Volunteers

1,079 people

Sponsor

Organon and Co